VRDN
Viridian Therapeutics, Inc. · Healthcare
Chief Medical Officer Barrett Katz sold $2.1M of Viridian Therapeutics, Inc.
Sold$2,089,472
$34.82Price
60,000Shares
−100%Stake
What VRDN did after the filing
- The stock from Wed, Jan 11 close, $35.39
- −7.0%
- S&P 500, same days
- +0.2%
Measured over 30 trading days, to the Feb 24 close.
Traded Mon, Jan 9. Filed Wed, Jan 11, 2:09 PM ET, during the session. Returns use the Jan 11 close and the Feb 24 close. Not investment advice.